Showing 1 - 20 results of 27 for search '"венозная мальформация"', query time: 0.61s Refine Results
  1. 1
  2. 2
    Academic Journal

    Source: Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care; Vol 13 (2023): Supplement; 162 ; Российский вестник детской хирургии, анестезиологии и реаниматологии; Vol 13 (2023): Supplement; 162 ; 2587-6554 ; 2219-4061 ; 10.17816/psaic.2023

    File Description: application/pdf

  3. 3
    Academic Journal

    Source: Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care; Vol 12 (2022): Supplement; 5 ; Российский вестник детской хирургии, анестезиологии и реаниматологии; Vol 12 (2022): Supplement; 5 ; 2587-6554 ; 2219-4061 ; 10.17816/psaic.2022

    File Description: application/pdf

  4. 4
  5. 5
  6. 6
  7. 7
    Academic Journal

    Source: Russian Journal of Pediatric Hematology and Oncology; Том 7, № 3 (2020); 22-31 ; Российский журнал детской гематологии и онкологии (РЖДГиО); Том 7, № 3 (2020); 22-31 ; 2413-5496 ; 2311-1267 ; 10.21682/2311-1267-2020-7-3

    File Description: application/pdf

    Relation: https://journal.nodgo.org/jour/article/view/621/567; ISSVA Classification of Vascular Anomalies©. 2018 International Society for the Study of Vascular Anomalies Accessed. [Electronic resource]: http://www.issva.org/classification.; Хачатрян Л.А., Клецкая И.С., Орехова Е.В. Синдромальная венозная мальформация – диссеминированный венозный ангиоматоз Бина. Вопросы гематологии/онкологии и иммунопатологии в педиатрии 2019;18(3):78–87. doi:10.24287/1726-1708-2019-18-3-78-87.; Yu Y., Flint A.F., Mulliken J.B., Wu J.K., Bischoff J. Endothelial progenitor cells in infantile hemangioma. Blood 2004;4(103):1373–5. doi:10.1182/blood-2003-08-2859.; Dickinson P., Christou E., Wargon O. A prospective stady of Infantile Hemangiomas with focus on incidence and risk factors. Pediatr Dermatology 2011;13:470–8. doi:10.1111/j.1525-1470.2011.01568.x.; Richter G.T., Friedman A.B. Hemangiomas and Vascular Malformations: Current Theory and Management. Int J Pediatric 2012;7:645–58. doi:10.1155/2012/645678.; Lyons L.L., North P.E., Mac-Moune Lai F., Stoler M., Folpe A., Weiss S. Kaposiform hemangioendothelioma: A study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol 2004;28:559–68. doi:10.1097/00000478-200405000-00001.; Hauer J., Graubner U., Konstantopoulos N., Schmidt S., Pfluger T., Schmid I. Effective treatment of kaposiform hemangioendotheliomas associated with Kasabach–Merritt phenomenon using four-drug regimen. Pediatr Blood Cancer 2007;49:852–4. doi:10.1002/pbc.20750.; Milliken J.B., Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982;69(3):412–22. doi:10.1097/00006534-198203000-00002.; Dompmartin A., Acher A., Thibon P., Tourbach S., Hermans C., Deneys V., Pocock B., Lequerrec A., Labbé D., Barrellier M., Vanwijck R., Vikkula M., Boon L. Association of localized intravascular coagulopathy with venous malformations. Arch Dermatology 2008;144:873–7. doi:10.1001/archderm.144.7.873.; Patel D.V. Gorham’s disease or massive osteolysis. Clin Med Res 2005;3(2):65–74. doi:10.3121/cmr.3.2.65.; Venkatramani R., Ma N.S., Pitukcheewanont P., Malogolowkin M., Mascarenhas L. Gorham’s disease and diffuse lymphangiomatosis in children and adolescents. Pediatr Blood Cancer 2011;56:667–70. doi:10.1002/pbc.22948.; Reinhardt M.A., Nelson S.C., Sencer S.F., Bostrom B., Kurachek S., Nesbit M. Treatment of childhood lymphangiomas with interferonalpha. J Pediatr Hematol Oncol 1997;19(3):232–6. doi:10.1097/00043426-199705000-00010.; Takahashi A., Ogawa C., Kanazawa T., Watanabe H., Suzuki M., Suzuki N., Tsuchida Y., Morikawa A., Kuwano H. Remission induced by interferon alfa in a patient with massive osteolysis and extension of lymph-hemangiomatosis: a severe case of Gorham-Stout syndrome. J Pediatr Surg 2005;40(3):E47–50. doi:10.1016/j.jpedsurg.2004.11.015.; Hammer F., Kenn W., Wesselmann U., Hof bauer L., Delling G., Allolio B., Arlt W. Gorham-Stout disease – stabilization during bisphosphonate treatment. J Bone Miner Res 2005;20(2):350–3. doi:10.1359/JBMR.041113.; Dickerhoff R., Bode V.U. Cyclophosphamide in non-resectable cystic hygroma. Lancet 1990;335(8703):1474–5. doi:10.1016/0140-6736(90)91512-9.; Grunewald T.G.P., Damke L., Maschan M., Petrova U., Surianinova O., Esipenko A., Konovalov D., Behrends U., Schiessl J., Wörtler K., Burdach S., Luettichau I. First report of effective and feasible treatment of multifocal lymphangiomatosis (Gorham-Stout) with bevacizumab in a child. Ann Oncol 2010;21:1733–4. doi: 0.1093/annonc/mdq331.; Deborah J.M., Toby N.T., Janet L.M., Martin J., Chee W., Walker J., Kirk E., Baxter R., Marshall G. Rapamycin treatment for a child with germline PTEN mutation. Nat Clin Pract Oncol 2008;5(6):357–61. doi:10.1038/ncponc1112.; Hammil A.M., Wentzel M., Gupta A., Stephen N., Anne L., Ravindhra E., Roshni D., Richard G.A., Denise M. Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer 2011;57:1018–24. doi:10.1002/pbc.23124.; Vézina С., Kudelski A., Sehgal S.N. Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J Antibiot (Tokyo) 1975;28(10):721–6. doi:10.7164/antibiotics.28.721.; Зубова С.Г., Шитикова Ж.В., Поспелова Т.В. TOR-центрическая концепция регуляции митогенных, метаболических и энергетических сигнальных путей в клетке. Цитология 2012;54(8):589– 602.; Красильников М.А., Жуков Н.В. Сигнальный путь mTOR: новая мишень терапии опухолей. Современная онкология 2010;2:9–16.; Официальные клинические практические рекомендации Американского торакального общества/Японского респираторного общества по диагностике и лечению лимфангиолейомиоматоза, 2016. [Электронный ресурс]: http://www.thoracic.org.; Freixo C., Ferreira V., Martins J., Almeida R., Caldeira D., Rosa M., Costa J., Ferreira J. Efficacy and safety of sirolimus in the treatment of vascular anomalies: A systematic review. J Vasc Surg 2020;1:318–27. doi:10.1016/j.jvs.2019.06.217.; https://journal.nodgo.org/jour/article/view/621

  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
    Academic Journal

    Source: Клінічна ендокринологія та ендокринна хірургія; № 2(27) (2009); 15-16
    Clinical endocrinology and endocrine surgery; № 2(27) (2009); 15-16
    Клиническая эндокринология и эндокринная хирургия; № 2(27) (2009); 15-16

    File Description: application/pdf

  18. 18
    Academic Journal

    Source: Український нейрохірургічний журнал; № 1 (2009); 59-60
    Украинский нейрохирургический журнал; № 1 (2009); 59-60
    Ukrainian Neurosurgical Journal; № 1 (2009); 59-60

    File Description: application/pdf

  19. 19
  20. 20